These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 278134)

  • 1. [Stomatitis and antimitotics (author's transl)].
    Cadenat H; Combelles R; Fabert G; Clouet M; Meites-Pero G
    Rev Stomatol Chir Maxillofac; 1978; 79(2):119-20. PubMed ID: 278134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced transverse white lines in the fingernails.
    James WD; Odom RB
    Arch Dermatol; 1983 Apr; 119(4):334-5. PubMed ID: 6340614
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
    Huys J; Van Vaerenbergh PM
    Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of combined treatment of advanced forms of multiple myeloma with vincristine, melphalan, cyclophosphamide and prednisone (VMCP) and with vincristine, doxorubicin, cyclophosphamide and prednisone (VDCP)].
    Robak T; Krykowski E; Płuzańska A; Olszańska-Skorek T; Urbańska-Ryś H; Polkowska-Kulesza E; Błasińska-Morawiec M; Mazurowa A
    Pol Tyg Lek; 1983 Apr; 38(16):481-4. PubMed ID: 6579509
    [No Abstract]   [Full Text] [Related]  

  • 5. Life with cytostatic drugs.
    Van Dam FS; Linssen AC; Engelsman E; van Benthem J; Hanewald GJ
    Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892
    [No Abstract]   [Full Text] [Related]  

  • 6. [The problem of accidental paravenous application of cytostatics--case history (author's transl)].
    Sommer H; Meinhold P
    Zentralbl Gynakol; 1981; 103(21):1324-8. PubMed ID: 6798785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual neuromuscular toxicity after treatment of bone sarcomas with adriamycin, vincristine, and cyclophosphamide.
    Sulis E
    Cancer Treat Rep; 1978 Sep; 62(9):1408-9. PubMed ID: 278643
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study.
    Bonnet J; Alexanian R; Salmon S; Bottomley R; Amare M; Haut A; Dixon D
    Cancer Treat Rep; 1982 Jun; 66(6):1267-71. PubMed ID: 7044534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
    Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
    Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
    Bui B; Chauvergne J; Durand M; Brunet R
    Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase 2 trial of liposomal doxorubicin (40 mg/m(2)) in platinum/paclitaxel-refractory ovarian and fallopian tube cancers and primary carcinoma of the peritoneum.
    Markman M; Kennedy A; Webster K; Peterson G; Kulp B; Belinson J
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):369-72. PubMed ID: 10985896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of stomatitis induced by anti-cancer drugs].
    Dozono H; Nakamura K; Motoya T; Nakamura S; Shinmura R; Miwa K; Ishibashi M; Nagata Y
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3449-51. PubMed ID: 2679397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease.
    Amadori S; Papa G; Anselmo AP; Fidani P; Mandelli F; Biagini C
    Cancer Treat Rep; 1983 Jun; 67(6):603-4. PubMed ID: 6190561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.